Smartkarma AI, Smartkarma

αSK

Smartkarma AI

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>CBOE's primary strength and competitive advantage lies in its exclusive, proprietary derivatives products, particularly the VIX and SPX suite, which generate significant, high-margin transaction revenue and create a wide economic moat.</li>
  <li>The company is strategically focused on global expansion, broadening its data and analytics services, and innovating in new asset classes like digital assets to diversify revenue streams and capture secular growth trends in global capital markets.</li>
  <li>Financial performance is robust, with a strong track record of revenue, net income, and dividend growth, though earnings remain sensitive to market volatility and trading volumes, which represent a key risk alongside intense competition and regulatory oversight.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  CBOE's primary strength and competitive advantage lies in its exclusive, proprietary derivatives products, particularly the VIX and SPX suite, which generate significant, high-margin transaction revenue and create a wide economic moat.
  The company is strategically focused on global expansion, broadening its data and analytics services, and innovating in new asset classes like digital assets to diversify revenue streams and capture secular growth trends in global capital markets.
  Financial performance is robust, with a strong track record of revenue, net income, and dividend growth, though earnings remain sensitive to market volatility and trading volumes, which represent a key risk alongside intense competition and regulatory oversight.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: CBOE Global Markets (CBOE US) - Sep 2025

Co-Founder & CEO, Newmark Risk

Nicholas Pezolano

Co-Founder & CEO

Option analytics for institutional investors

Newmark Risk

Fin-tech company focused on providing option derived analytics for institutional investors.

We handle the complexity of options data so you don't have to.

- Data and Analytics available all in one place so you can focus on Strategy Development
- Custom Solutions for your data and/or portfolio needs
- Advisory services to lend our expertise

Knowledge is something that was meant to be shared and we provide insights to our clients and to the community via posting about our research findings.

Quantitative Analysis

<ul>
<li>HKEX has launched weekly stock options for 10 listed equities on 2024-11-04.</li>
<li>We explore recent HKEX volume trends and believe this may be a positive catalyst for HKEX.</li>
<li>HKEX may prove to be a catalyst for more equity option product development in the region.</li>
</ul>


HKEX has launched weekly stock options for 10 listed equities on 2024-11-04.
We explore recent HKEX volume trends and believe this may be a positive catalyst for HKEX.
HKEX may prove to be a catalyst for more equity option product development in the region.


EQD | HKEX Weekly Equity Options off to a Strong Start

Asset Allocation & Fund Positioning, Copley Fund Research

Steven Holden

Asset Allocation & Fund Positioning

Copley Fund Research

Copley Fund Research provide research and data on asset allocation among Global and Emerging Market equity funds.  The analysis details absolute and relative positioning across countries, sectors and industries together with highly granular data on single stock and single fund allocations.  The data is updated monthly with time series going back to January 2011.

Global Research - Analysis of 165 prominent Global equity funds, combined AUM $335bn
GEM Research - Analysis of 127 prominent global EM equity funds, combined AUM $250bn

Asset Allocation - Global and GEM Equity

<ul>
<li>Financials Exchanges have hit record highs in Global fund ownership, with 58% of global funds invested and 49% ahead of the MSCI ACWI index.</li>
<li>CME Group and London Stock Exchange lead momentum, both reaching record ownership after strong inflows through 2023–2024.</li>
<li>Despite growth, ownership breadth remains shallow, with only a few stocks widely held, leaving room for further expansion in positioning.</li>
</ul>


Financials Exchanges have hit record highs in Global fund ownership, with 58% of global funds invested and 49% ahead of the MSCI ACWI index.
CME Group and London Stock Exchange lead momentum, both reaching record ownership after strong inflows through 2023–2024.
Despite growth, ownership breadth remains shallow, with only a few stocks widely held, leaving room for further expansion in positioning.


Global Financial Exchanges: A Sector on the Rise

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<ul>
<li>The S&amp;P 500 (SPX) is back to test YTD highs and important resistance in the 5670-5783 range. This is an important target/resistance area we have discussed for weeks.</li>
<li>Using the 2007 SPX topping analog suggests a 2% or less move above the prior all-time high set in July at 5670 before topping, which gives the 5783 number.</li>
<li>As long as SPX does not have a weekly close above 5783 we continue to recommend reducing risk and shifting to defensives,and this is the ideal time to do so.</li>
</ul>


The S&amp;P 500 (SPX) is back to test YTD highs and important resistance in the 5670-5783 range. This is an important target/resistance area we have discussed for weeks.
Using the 2007 SPX topping analog suggests a 2% or less move above the prior all-time high set in July at 5670 before topping, which gives the 5783 number.
As long as SPX does not have a weekly close above 5783 we continue to recommend reducing risk and shifting to defensives,and this is the ideal time to do so.


SPX Testing Resistance as Rate Cut Cycle Begins; SPX 5670-5783 Is Resistance, 2007 Analog on Track

Financials & FinTech research, Galliano’s Financials Research

Victor Galliano

Financials & FinTech research

Financials & FinTech, EM & Developed Markets

Galliano’s Financials Research

Galliano's Financials Research provides fundamental research in Emerging Markets financials, including FinTech, as well as financials in select Developed Markets.

The investment style applied is generally value oriented, although Growth At Reasonable Price (GARP) strategies can also be used where appropriate. 

Our investment research approach aim is often contrarian, looking to capitalise on overly sceptical or optimistic consensus views. In terms of valuation techniques, the focus is on PBV ratio to ROE, PE multiples and dividend yield, as well as the application of PEG ratios and, where appropriate, Sum of the Parts (SOTP) valuations.

Thematic (Sector/Industry)

<ul>
<li>Our core pick is flow monster CME Group for its dominant franchise through its trading and post-trading (including clearing) operations in interest rates, equity indices, foreign exchange and commodity derivatives</li>
<li>We also like Deutsche Borse as the European flow monster and for its attractive valuations and gearing into greater European securities activity</li>
<li>We downgrade Japan Exchange to a neutral from buy for its fair valuations, as we see more compelling opportunities with CME group and Deutsche Borse; CBOE is one to watch</li>
</ul>


Our core pick is flow monster CME Group for its dominant franchise through its trading and post-trading (including clearing) operations in interest rates, equity indices, foreign exchange and commodity derivatives
We also like Deutsche Borse as the European flow monster and for its attractive valuations and gearing into greater European securities activity
We downgrade Japan Exchange to a neutral from buy for its fair valuations, as we see more compelling opportunities with CME group and Deutsche Borse; CBOE is one to watch


Developed Market Exchanges – Integrated Flow Monsters and Big Data Monetisers

United States

CBOE Global Markets, Inc. operates a marketplace for the trading of standardized, listed options on equity securities. The Company is recognized for its role in the trading of options on individual equities, market indexes and exchange-traded funds, their suite of products, their markets and their hybrid trading model.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CBOE Global Markets (CBOE US)

Primer: CBOE Global Markets (CBOE US) - Sep 2025

CBOE's primary strength and competitive advantage lies in its exclusive, proprietary derivatives products, particularly the VIX and SPX suite,...

αSK

EQD | HKEX Weekly Equity Options off to a Strong Start

HKEX introduces weekly stock options, potentially boosting volume and driving further equity option product development in the region.

Nicholas Pezolano

Global Financial Exchanges: A Sector on the Rise

Financials Exchanges are at record exposure levels, led by CME and LSE. Momentum is strong, but breadth is shallow, with few stocks widely...

Steven Holden

SPX Testing Resistance as Rate Cut Cycle Begins; SPX 5670-5783 Is Resistance, 2007 Analog on Track

$SPX Testing Resistance as Rate Cut Cycle Begins; SPX 5670-5783 is Resistance, 2007 Analog on Track if Below 5783. Still Neutral, prefer to sell...

Vermilion Research

Developed Market Exchanges – Integrated Flow Monsters and Big Data Monetisers

CME Group is our top pick for its dominant market position in key US derivatives, Deutsche Borse is also on the buy list. We downgrade Japan...

Victor Galliano

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Primer: CBOE Global Markets (CBOE US) - Sep 2025

CBOE's primary strength and competitive advantage lies in its exclusive, proprietary derivatives products, particularly the VIX and SPX suite,...

αSK

EQD | HKEX Weekly Equity Options off to a Strong Start

​HKEX introduces weekly stock options, potentially boosting volume and driving further equity option product development in the region.

Nicholas Pezolano

Global Financial Exchanges: A Sector on the Rise

Financials Exchanges are at record exposure levels, led by CME and LSE. Momentum is strong, but breadth is shallow, with few stocks widely...

Steven Holden

SPX Testing Resistance as Rate Cut Cycle Begins; SPX 5670-5783 Is Resistance, 2007 Analog on Track

$SPX Testing Resistance as Rate Cut Cycle Begins; SPX 5670-5783 is Resistance, 2007 Analog on Track if Below 5783. Still Neutral, prefer to sell...

Vermilion Research

Developed Market Exchanges – Integrated Flow Monsters and Big Data Monetisers

​CME Group is our top pick for its dominant market position in key US derivatives, Deutsche Borse is also on the buy list. We downgrade Japan...

Victor Galliano

HKEX introduces weekly stock options, potentially boosting volume and driving further equity option product development in the region.

CME Group is our top pick for its dominant market position in key US derivatives, Deutsche Borse is also on the buy list. We downgrade Japan...